Canada markets closed

Blueprint Medicines Corp (2L9.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
95.76-3.22 (-3.25%)
At close: 09:59PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-288,288
-506,984
-557,517
-644,085
313,882
Depreciation & amortization
12,791
11,665
11,735
6,479
6,559
Stock based compensation
93,701
92,672
98,971
91,630
75,526
Change in working capital
-57,910
-41,128
-53,769
-23,680
-15,618
Accounts receivable
-33,105
-20,715
1,572
-18,143
-6,387
Inventory
-1,748
-4,366
-8,922
-12,561
-6,707
Accounts Payable
-5,613
1,880
-5,816
4,221
-791
Other working capital
-429,981
-452,909
-511,196
-559,894
383,876
Other non-cash items
18,244
24,394
-715
269,642
6,220
Net cash provided by operating activites
-415,399
-436,847
-502,277
-298,653
387,035
Cash flows from investing activities
Investments in property, plant and equipment
-14,582
-16,062
-8,919
-261,241
-3,159
Purchases of investments
-833,653
-766,363
-489,705
-655,449
-969,437
Sales/Maturities of investments
1,026,615
1,056,465
349,373
690,830
538,347
Other investing activites
-
-
-290
-
-
Net cash used for investing activites
178,380
274,040
-149,541
-225,860
-434,249
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
-
-
0
0
582,494
Other financing activites
-359
-44
415,828
-
-
Net cash used privided by (used for) financing activities
186,188
119,225
561,810
50,716
617,759
Net change in cash
-50,831
-43,582
-90,008
-473,797
570,545
Cash at beginning of period
174,931
124,904
215,119
689,804
119,604
Cash at end of period
124,100
81,524
124,904
215,119
689,804
Free Cash Flow
Operating Cash Flow
-415,399
-436,847
-502,277
-298,653
387,035
Capital Expenditure
-14,582
-16,062
-8,919
-261,241
-3,159
Free Cash Flow
-429,981
-452,909
-511,196
-559,894
383,876